Canaccord Reiterates Hold Rating on Repligen (RGEN)

July 29, 2026 6:47 AM

Canaccord analyst Kyle Mikson reiterated a Hold rating and $145.00 price target on Repligen (NASDAQ: RGEN).The analyst commented: "We reiterate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found